Blocking TMEM141 Reduces MASH and Fibrosis Through ROS-HNF4α Pathway
A groundbreaking study has unveiled a promising therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, two increasingly prevalent ...
A groundbreaking study has unveiled a promising therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, two increasingly prevalent ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine